Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:27:02 EDT Fri 09 May 2025
Enter Symbol
or Name
USA
CA



Z:BDX - BECTON DICKINSON & CO - https://www.bd.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BDX - Z0.1167.31·167.884.9167.12-0.83-0.54,133.7695,50633,806168.50  170.33  166.88251.93  163.3317:49:42May 0115 min RT 2¢

Recent Trades - Last 10 of 33806
Time ETExPriceChangeVolume
17:49:42Z167.88-0.071
17:37:57Z170.002.051
17:19:35Z170.402.452
16:55:08Z167.50-0.453
16:55:08Z167.50-0.451
16:55:08Z167.50-0.4516
16:46:54Z168.000.052
16:43:13Z168.000.051
16:39:54Z167.22-0.73455
16:26:05Z167.22-0.733,029

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-05-01 06:30U:BDXNews ReleaseBD Reports Second Quarter Fiscal 2025 Financial Results
2025-04-30 16:15U:BDXNews ReleaseBD to Present at Bank of America Securities Health Care Conference
2025-04-29 16:20U:BDXNews ReleaseBD Board Declares Dividend
2025-04-23 06:50U:BDXNews ReleaseBD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair
2025-04-21 06:50U:BDXNews ReleaseBD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision Support
2025-04-03 16:15U:BDXNews ReleaseBD to Announce Financial Results for its Second Quarter of Fiscal 2025
2025-03-31 06:50U:BDXNews ReleaseBD Named One of America's Most Innovative Companies by Fortune
2025-03-27 16:15U:BDXNews ReleaseBD Names Gregory J. Hayes to Board of Directors
2025-03-20 06:50U:BDXNews ReleaseBD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE(TM) Scaffold in Breast Implant Revision Surgery
2025-02-13 16:15U:BDXNews ReleaseBD to Present at Investor Healthcare Conferences
2025-02-05 16:30U:BDXNews ReleaseBD Reports First Quarter Fiscal 2025 Financial Results
2025-02-05 16:30U:BDXNews ReleaseBD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value
2025-01-28 16:15U:BDXNews ReleaseBD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $750 Million Repurchase to Date in FY25
2025-01-23 07:15U:BDXNews ReleaseBD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development
2025-01-22 06:50U:BDXNews ReleaseCarilion Clinic First in Virginia to Offer Needle-free In-patient Blood Draws, Redefining Patient Standard of Care
2025-01-16 16:15U:BDXNews ReleaseBD to Announce Financial Results for its First Quarter of Fiscal 2025
2025-01-15 06:50U:BDXNews ReleaseNew Survey Reveals Nearly 3 in 4 Canadian Women Are Delaying Their OB/GYN Exams, Increasing Risks for Cervical Cancer
2025-01-15 06:50U:BDXNews ReleaseBD Boosts U.S. Manufacturing of Critical Medical Devices
2025-01-13 06:50U:BDXNews ReleaseNew ASCCP Guidelines Include More Precise Method of Cervical Cancer Screening
2025-01-10 06:50U:BDXNews ReleaseBD Names Pamela Spikner as Chief Accounting Officer and Controller